Position in BIIB
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$419,804
-$83,803 QoQ
Shares Held
1,943
-29.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#602
of 1,038 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Waterfront Wealth Inc. holds $12,907,533 across 9 Drug Manufacturers - General names. BIIB ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRN |
Amarin Corp Plc\Uk
|
213,949 | $3,410,347 | |
| 2 | ABBV |
AbbVie Inc.
|
10,643 | $2,678,204 | |
| 3 | SNY |
Sanofi
|
60,460 | $2,579,223 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
33,448 | $1,927,273 | |
| 5 | JNJ |
Johnson & Johnson
|
3,263 | $828,704 | |
| 6 | BIIB |
Biogen Inc.
This page
|
1,943 | $419,804 | |
| 7 | PFE |
Pfizer Inc
|
16,362 | $393,996 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,647 | $340,139 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,804 | 1,943 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $503,607 | 2,747 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $487,316 | 2,769 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $382,558 | 2,731 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $217,986 | 1,593 | Shares | Sole | 2025-04-25 | |
| 2021-09-30 | $215,072 | 760 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $268,359 | 775 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $218,764 | 782 | Shares | Sole | 2021-04-23 | |
| No filing history on record for this holder in this stock. | ||||||